Eurican DAPPi L Multi 10x1 ds
Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.
En stock
Eurican DAPPi L Multi 10x1 ds
Vaccine for dogs against Viral Hepatitis (CAV), Distemper (CDV), Leptospira Interrogans, Para-influenza (PCiV) and Canine Parvo (CPV).
For active immunization of dogs for:
- the prevention of mortality and clinical signs caused by distemper virus (CDV),
- the prevention of mortality and clinical signs caused by infectious canine hepatitis virus (CAV),
- the reduction of viral excretion during respiratory illness caused by canine adenovirus type 2 (CAV-2),
- the prevention of mortality, clinical signs and viral excretion caused by canine parvovirus (CPV),
- the reduction of viral excretion caused by canine parainfluenza virus type 2 (CPiV)
- the prevention of mortality, clinical signs, infection, bacterial excretion, formation of a renal reservoir and renal lesions caused by Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae,
- the prevention of mortality and clinical signs, reduction of infection, bacterial excretion, formation of a renal reservoir and renal lesions caused by Leptospira interrogans serogroup Canicola serovar Canicola,
- the prevention of mortality and reduction of clinical signs, infection, bacterial excretion, formation of a renal reservoir and renal lesions caused by Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa.
- the prevention of mortality, clinical signs, renal infection, bacterial excretion, formation of a renal reservoir and renal lesions caused by Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni.
Onset of immunity: The vaccine provides immunity 2 weeks after administering the second injection of the primary vaccination course.
Duration of immunity: At least one year after the second injection of the primary vaccination course for all strains.
Indications d'utilisation
The entire contents of the constituted vial should be administered subcutaneously (SC) as one dose.
Primary vaccination course: Two injections at 4-week intervals starting at 7 weeks of age. Revaccination: Administer one dose 12 months after completing the primary vaccination course.
Attenuated canine distemper virus, strain BA5 104.0 CCID50* 106.0 CCID50*
Attenuated Canine Adenovirus type 2, strain DK13 102.5 CCID50* 106.3 CCID50*
Attenuated Canine Parvovirus type 2, strain CAG2 104.9 CCID50* 107.1 CCID50*
Attenuated Canine Parainfluenza virus type 2, strain CGF 2004/75 (* CCID50: 50% cell culture infective dose)